Role of mitochondria as the gardens of cell death Ryungsa KimManabu EmiKazuaki Tanabe Review 21 September 2005 Pages: 545 - 553
Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer: results from a pilot trial Rupert BartschCatharina WenzelGuenther G. Steger Original Article 23 August 2005 Pages: 554 - 558
Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer Kathleen E. RodgersJamie OliverGere S. diZerega Original Article 12 August 2005 Pages: 559 - 568
CYP1A1 activation of aminoflavone leads to DNA damage in human tumor cell lines Lori J. PobstMatthew M. Ames Original Article 11 August 2005 Pages: 569 - 576
The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer Yutaka OgataKeiko MatonoKazuo Shirouzu Original Article 20 August 2005 Pages: 577 - 583
Antimetastatic effect of a lipophilic ascorbic acid derivative with antioxidation through inhibition of tumor invasion Jianwen LiuXiaodong ZhangYuhong Ren Original Article 02 August 2005 Pages: 584 - 590
Pharmacokinetic and cytotoxic studies of pegylated liposomal daunorubicin Haifeng SongJin ZhangJie Ma Original Article 30 August 2005 Pages: 591 - 598
Thalidomide does not interact with P-glycoprotein Christian ZimmermannHeike GutmannJuergen Drewe Original Article 01 September 2005 Pages: 599 - 606
Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl Mao LiHui WangRuiwen Zhang Original Article 06 December 2005 Pages: 607 - 614
Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patients Alessandra FabiGianluigi FerrettiFrancesco Cognetti Original Article 15 September 2005 Pages: 615 - 623
Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin’s and non-Hodgkin’s lymphoma and a preliminary study on the toxicity of etoposide associated with LDE Ketlin V. PinheiroVania T. M. HungriaRaul C. Maranhão Original Article 25 August 2005 Pages: 624 - 630
Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumors William C. ZamboniSanjay GoelSridhar Mani Original Article 05 October 2005 Pages: 631 - 639
High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer V. HeinemannH. J. StemmlerG. Rauthe Original Article 15 September 2005 Pages: 640 - 646
Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer Takuji OkusakaHiroshi IshiiToshio Tsuyuguchi Original Article 02 September 2005 Pages: 647 - 653
Pharmacokinetics and biodistribution of the camptothecin–polymer conjugate IT-101 in rats and tumor-bearing mice Thomas SchluepJianjun ChengMark E. Davis Original Article 26 August 2005 Pages: 654 - 662
Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy Maria Angélica O. MendonçaFernando Q. CunhaBeatriz M. Tavares-Murta Original Article 27 August 2005 Pages: 663 - 670
A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors Matthew G. FuryLee M. KrugNaiyer A. Rizvi Original Article 31 August 2005 Pages: 671 - 677
A phase I study of monohydroxyethylrutoside in healthy volunteers Anja M. WillemsAnne M. BruynzeelWim J. van der Vijgh Original Article 01 September 2005 Pages: 678 - 684
Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics Chetan LathiaJohn LettieriPavur Sundaresan Original Article 25 August 2005 Pages: 685 - 692
Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models Kaori F. -OuchiMieko YanagisawaYutaka Tanaka Original Article 16 December 2005 Pages: 693 - 702
Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C Paul H. SugarbakerO. Anthony StuartC. Pablo Carmignani Original Article 11 August 2005 Pages: 703 - 708
